BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11054450)

  • 1. Docetaxel as second-line chemotherapy for non-small-cell lung cancer.
    Roila F; Del Favero A; Ballatori E
    J Clin Oncol; 2000 Nov; 18(21):3738-9. PubMed ID: 11054450
    [No Abstract]   [Full Text] [Related]  

  • 2. The development of docetaxel (Taxotere) in non-small cell lung cancer.
    Kris MG; Miller VA; Ng KK; Grant SC
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-1-S14-4. PubMed ID: 9335515
    [No Abstract]   [Full Text] [Related]  

  • 3. Expanding horizons: an update on the use of docetaxel in non-small cell lung, ovarian, and breast cancers.
    Hortobagyi GN; Kris MG
    Semin Oncol; 2002 Jun; 29(3 Suppl 12):1-3. PubMed ID: 12170444
    [No Abstract]   [Full Text] [Related]  

  • 4. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer.
    Kris MG; Millward M
    Semin Oncol; 1999 Jun; 26(3 Suppl 10):1-2. PubMed ID: 10437742
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of taxanes in lung-cancer chemotherapy.
    Schiller JH
    Cancer Invest; 1998; 16(7):471-7. PubMed ID: 9774954
    [No Abstract]   [Full Text] [Related]  

  • 6. Docetaxel for previously treated non-small-cell lung cancer.
    Fossella FV
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):45-51. PubMed ID: 12108897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New options in the treatment of non-small cell lung cancer.
    Fossella F; Rigas JR; Belani CP
    Anticancer Drugs; 1999 Nov; 10 Suppl 1():S25-8. PubMed ID: 10630365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: recent results and future developments.
    Rosell R
    Semin Oncol; 1999 Jun; 26(3 Suppl 11):1-3. PubMed ID: 10458202
    [No Abstract]   [Full Text] [Related]  

  • 9. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: an international update.
    Kris MG; Manegold C
    Semin Oncol; 2001 Feb; 28(1 Suppl 2):1-3. PubMed ID: 11284618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel in the treatment of non-small cell lung cancer: review of single-agent trials.
    Fossella FV
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):17-23; discussion 41-2. PubMed ID: 10585004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The taxanes: an update.
    Crown J; O'Leary M
    Lancet; 2000 Apr; 355(9210):1176-8. PubMed ID: 10791395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel (Taxotere) in the treatment of cancer.
    Burris HA
    Semin Oncol; 2000 Apr; 27(2 Suppl 3):1-2. PubMed ID: 10810931
    [No Abstract]   [Full Text] [Related]  

  • 13. Overview of docetaxel (Taxotere) in the treatment of non-small cell lung cancer.
    Fossella FV
    Semin Oncol; 1999 Jun; 26(3 Suppl 11):4-8. PubMed ID: 10458203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer (NSCLC)--is there a role for a new chemotherapy programme?
    Armand JP
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():223-30. PubMed ID: 10895158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epiphora induced by intermittent docetaxel (taxotere) in patients with non-small cell lung cancer.
    Spell DW; Estephan FF; Lin JT; Jones DV
    Cancer Invest; 2003; 21(4):550-2. PubMed ID: 14533445
    [No Abstract]   [Full Text] [Related]  

  • 16. The current status of docetaxel for advanced non-small cell lung cancer.
    Green MR
    Anticancer Drugs; 2001 Feb; 12 Suppl 1():S11-6. PubMed ID: 11340898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
    Belani CP
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel: current status and future prospects.
    Eisenhauer E
    J Clin Oncol; 1995 Dec; 13(12):2865-8. PubMed ID: 8523048
    [No Abstract]   [Full Text] [Related]  

  • 19. Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: a review of two phase III trials.
    Shepherd FA; Fossella FV; Lynch T; Armand JP; Rigas JR; Kris MG
    Semin Oncol; 2001 Feb; 28(1 Suppl 2):4-9. PubMed ID: 11284623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel in the management of advanced non-small cell lung cancer.
    Miller VA
    Semin Oncol; 1998 Jun; 25(3 Suppl 8):15-9. PubMed ID: 9704671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.